Therapeutics Hormonal Agents

The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism

Bayram F, Sahin Y, Keleştimur F, Tutuş A, Ayata D, Müderris II

Published August 1996 Fertility and Sterility, 66(2), 220-222
DOI 10.1016/s0015-0282(16)58442-8 PMID 8690105

Abstract

Objective

To investigate the effects of low dose flutamide (250 mg/d) on hirsutism score and hormone levels in women with hirsutism.

Design

Nonrandomized, prospective clinical trial.

Patients

Forty-one patients with moderate-severe hirsutism were included in the study.

Intervention

Hirsute patients received 250 mg/d flutamide for a period of 6 months.

Main Outcome Measures

Hirsutism score, FSH, LH, E2, total T, free T, androstenedione, DHEAS, PRL, 17-hydroxyprogesterone, and sex hormone-binding globulin levels were detected in all the patients before treatment and every 3 months during treatment.

Results

Treatment with the antiandrogen flutamide resulted in a particularly rapid and marked decrease in the hirsutism score, which decreased from 17.48 +/- 5.35 to 5.07 +/- 2.89 after 6 months. No significant changes in the levels of hormone and no serious side effects were observed in the study.

Conclusion

The low-dose flutamide, 250 mg/d, is a cost-effective drug in the treatment of hirsutism. Low-dose flutamide may be used in place of high-dose flutamide, 500 to 750 mg/d.

Topics

By this author

Related research

Therapeutics › Hormonal Agents › Androgens and DHEA
Iptisam Ipek Muderris, Fahri Bayram, Fahrettin Keleştimur, Ahmet Tutuş
I Muderris, F Bayram, F Keleştimur, A Tutuş
PMID 8690105 8690105 DOI 10.1016/s0015-0282(16)58442-8 10.1016/s0015-0282(16)58442-8 Bayram et al. 1996, Bayram 1996